MXCT 3.49 (+4.8%)
US57777K1060• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. MXCT

MaxCyte (MXCT) Competitor Comparison

We are evaluating the key criteria listed to compare MaxCyte (MXCT) against its competitors in the Diagnostics & Research industry.

Market Capitalization

36 / 58

Gross Profits

40 / 52

Total Revenue

46 / 57

EBITDA

45 / 56

Free Cashflow

44 / 56

Quick Ratio

3 / 57

Earnings per Share

27 / 56

Dividend yield

0 / 9

Total Cash

27 / 57

Performance 3 years

41 / 58

Performance 5 years

47 / 58

Performance 10 years

43 / 58

Linearity 3 years

37 / 58

Linearity 5 years

48 / 58

Linearity 10 years

29 / 58

Total Rank

20 / 58

Dividend Rank

58 / 58

Valuation Rank

26 / 58

Piotroski Rank

47 / 58

Muliplier Rank

51 / 58

Performance 3 years - MXCT ranking 41 / 58

These are the competitors of MaxCyte in the industry Diagnostics & Research ranked by performance 3 years
1. Meridian Bioscience VIVO
246.63
2. Lantheus Holdings LNTH
165.31
3. RadNet RDNT
155.39
4. Heska HSKA
41.31
5. Medpace Holdings MEDP
39.92
6. Natera NTRA
27.01
7. PerkinElmer PKI
21.19
8. Ortho Clinical Diagnostics Holdings OCDX
13.74
9. Quest Diagnostics DGX
7.08
10. Waters WAT
0.15
11. Laboratory Corp of America Holdings LH
-6.85
12. Danaher DHR
-14.49
13. Syneos Health SYNH
-19.01
14. Thermo Fisher Scientific TMO
-19.4
15. Agilent Technologies A
-21.2
16. Qiagen QGEN
-21.91
17. Olink Holding OLK
-22.2
18. Mettler-Toledo MTD
-23.08
19. IQVIA Holdings IQV
-24.41
20. Bioventus BVS
-29.11
21. IDEXX Laboratories IDXX
-32.93
22. Anixa Biosciences ANIX
-33.12
23. Icon ICLR
-33.49
24. Sotera Health SHC
-35.55
25. Sera Prognostics SERA
-40.65
26. Exact Sciences EXAS
-44.44
27. Myriad Genetics MYGN
-48.3
28. Charles River Laboratories CRL
-51.17
29. DexCom DXCM
-53.3
30. CareDx CDNA
-54.83
31. National Research NRC
-60.42
32. Interpace Biosciences IDXG
-61.28
33. NeoGenomics NEO
-62.33
34. Illumina ILMN
-63.89
35. Enzo Biochem ENZ
-66.37
36. Twist Bioscience TWST
-66.66
37. Neogen NEOG
-66.95
38. Global Cord Blood CO
-67.25
39. Guardant Health GH
-70.94
40. Psychemedics PMD
-72.4
41. MaxCyte MXCT
-72.81
42. Personalis PSNL
-76.64
43. Exagen XGN
-77.57
44. Fulgent Genetics FLGT
-80.07
45. Biodesix BDSX
-81.36
46. MDxHealth MDXH
-84.09
47. bioAffinity Technologies BIAF
-84.17
48. Trinity Biotech TRIB
-84.9
49. Precipio PRPO
-86.86
50. Co-Diagnostics CODX
-88.54
51. Organovo Holdings ONVO
-89.19
52. Neuronetics STIM
-91.07
53. Pacific Biosciences of California PACB
-93.24
54. DarioHealth DRIO
-93.77
55. Inotiv NOTV
-95.13
56. SeqLL SQL
-95.69
57. Prenetics Global PRE
-95.82
58. Aspira Womens Health AWH
-98.83
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.